Integra LifeSciences Announces Completion of Its Multicenter Clinical Trial for the Treatment of Diabetic Foot Ulcers

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Integra LifeSciences Announces Completion of Its Multicenter Clinical Trial for the Treatment of Diabetic Foot Ulcers

Integra Lifesciences (IART) Tops Q2 EPS by 4c

August 5, 2014 6:51 AM EDT

Integra Lifesciences (NASDAQ: IART) reported Q2 EPS of $0.68, $0.04 better than the analyst estimate of $0.64. Revenue for the quarter came in at $231.4 million versus the consensus estimate of $229.32 million.

For earnings history and earnings-related data on Integra Lifesciences (IART) click here.

... More